Skip to main content
Top
Published in: Journal of Gastroenterology 4/2024

08-02-2024 | Editorial

Role of combined aerobic and resistance exercise in liver cirrhosis

Authors: Tadashi Namisaki, Shinya Sato, Hitoshi Yoshiji

Published in: Journal of Gastroenterology | Issue 4/2024

Login to get access

Excerpt

In this issue, Kawaguchi et al. investigated the effects of aerobic and resistance exercise on hepatic complications in patients with liver cirrhosis (LC) of different etiologies [1]. A meta-analysis of 11 randomized controlled trials (RCTs) found that exercise has a significant effect on the incidence of serious events including liver function capacity, or patient-reported outcomes. Moreover, resistance exercise reduced the incidence of serious events, including liver failure, hepatocellular carcinoma (HCC), and infection, by reducing sarcopenia in patients with LC. Sarcopenia is a risk factor for serious events [2, 3] in patients with LC, worsening with decreased hepatic synthetic capacity [4]. Several RCTs have demonstrated that 8–14 weeks of exercise improved sarcopenia in patients with Child–Pugh class A (CPA) and Child–Pugh class B (CPB) LC in the Evidence-Based Clinical Practice Guidelines for Liver Cirrhosis 2020 [58]. …
Literature
2.
go back to reference Topan MM, Sporea I, Danila M, et al. Impact of sarcopenia on survival and clinical outcomes in patients with liver cirrhosis. Front Nutr. 2021;8:766451.CrossRefPubMedPubMedCentral Topan MM, Sporea I, Danila M, et al. Impact of sarcopenia on survival and clinical outcomes in patients with liver cirrhosis. Front Nutr. 2021;8:766451.CrossRefPubMedPubMedCentral
3.
go back to reference Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76:588–99.CrossRefPubMed Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76:588–99.CrossRefPubMed
4.
go back to reference Hanai T, Shiraki M, Ohnishi S, et al. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis. Hepatol Res. 2016;46:743–51.CrossRefPubMed Hanai T, Shiraki M, Ohnishi S, et al. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis. Hepatol Res. 2016;46:743–51.CrossRefPubMed
5.
go back to reference Roman E, Garcia-Galceran C, Torrades T, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS ONE. 2016;11:e0151652.CrossRefPubMedPubMedCentral Roman E, Garcia-Galceran C, Torrades T, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS ONE. 2016;11:e0151652.CrossRefPubMedPubMedCentral
6.
go back to reference Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920-6.e2.CrossRefPubMed Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920-6.e2.CrossRefPubMed
7.
go back to reference Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180.CrossRefPubMedPubMedCentral Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180.CrossRefPubMedPubMedCentral
8.
go back to reference Kruger C, McNeely ML, Bailey RJ, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99.CrossRefPubMedPubMedCentral Kruger C, McNeely ML, Bailey RJ, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99.CrossRefPubMedPubMedCentral
9.
go back to reference Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6.CrossRefPubMed Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6.CrossRefPubMed
10.
go back to reference Salo J, Guevara M, Fernandez-Esparrach G, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–42.CrossRefPubMed Salo J, Guevara M, Fernandez-Esparrach G, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–42.CrossRefPubMed
11.
12.
go back to reference Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51:725–49.CrossRefPubMed Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51:725–49.CrossRefPubMed
13.
go back to reference Luo X, Yang W, Ma Y, et al. Physical activity and risk of hepatocellular carcinoma among U.S. men and women. Cancer Prev Res. 2020;13:707–14.CrossRef Luo X, Yang W, Ma Y, et al. Physical activity and risk of hepatocellular carcinoma among U.S. men and women. Cancer Prev Res. 2020;13:707–14.CrossRef
14.
go back to reference Aamann L, Tandon P, Bemeur C. Role of exercise in the management of hepatic encephalopathy: experience from animal and human studies. J Clin Exp Hepatol. 2019;9:131–6.CrossRefPubMed Aamann L, Tandon P, Bemeur C. Role of exercise in the management of hepatic encephalopathy: experience from animal and human studies. J Clin Exp Hepatol. 2019;9:131–6.CrossRefPubMed
15.
go back to reference Wallen MP, Keating SE, Hall A, et al. Exercise training is safe and feasible in patients awaiting liver transplantation: a pilot randomized controlled trial. Liver Transpl. 2019;25:1576–80.CrossRefPubMed Wallen MP, Keating SE, Hall A, et al. Exercise training is safe and feasible in patients awaiting liver transplantation: a pilot randomized controlled trial. Liver Transpl. 2019;25:1576–80.CrossRefPubMed
16.
go back to reference Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2018;42:205–15.CrossRefPubMed Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2018;42:205–15.CrossRefPubMed
17.
go back to reference Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, et al. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–39.CrossRefPubMed Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, et al. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–39.CrossRefPubMed
18.
go back to reference Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012;18:146–51.CrossRefPubMed Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012;18:146–51.CrossRefPubMed
19.
go back to reference Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: Translating evidence and experience to practice. J Hepatol. 2018;69:1164–77.CrossRefPubMed Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: Translating evidence and experience to practice. J Hepatol. 2018;69:1164–77.CrossRefPubMed
20.
go back to reference Morkane CM, Kearney O, Bruce DA, et al. An outpatient hospital-based exercise training program for patients with cirrhotic liver disease awaiting transplantation: a feasibility trial. Transplantation. 2020;104:97–103.CrossRefPubMed Morkane CM, Kearney O, Bruce DA, et al. An outpatient hospital-based exercise training program for patients with cirrhotic liver disease awaiting transplantation: a feasibility trial. Transplantation. 2020;104:97–103.CrossRefPubMed
21.
go back to reference Nishida Y, Ide Y, Okada M, et al. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193-200.CrossRefPubMed Nishida Y, Ide Y, Okada M, et al. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193-200.CrossRefPubMed
22.
go back to reference Hiraoka A, Michitaka K, Kiguchi D, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416–23.CrossRefPubMed Hiraoka A, Michitaka K, Kiguchi D, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416–23.CrossRefPubMed
23.
go back to reference Chen HW, Ferrando A, White MG, et al. Home-based physical activity and diet intervention to improve physical function in advanced liver disease: a randomized pilot trial. Dig Dis Sci. 2020;65:3350–9.CrossRefPubMed Chen HW, Ferrando A, White MG, et al. Home-based physical activity and diet intervention to improve physical function in advanced liver disease: a randomized pilot trial. Dig Dis Sci. 2020;65:3350–9.CrossRefPubMed
Metadata
Title
Role of combined aerobic and resistance exercise in liver cirrhosis
Authors
Tadashi Namisaki
Shinya Sato
Hitoshi Yoshiji
Publication date
08-02-2024
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology / Issue 4/2024
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-024-02078-y

Other articles of this Issue 4/2024

Journal of Gastroenterology 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.